Dermatology Life Quality Index

Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both

410. Chen, Y., Yu, M., Huang, X., Tu, P., Shi, P., Maurer, M.+*, and Zhao, Z.+*: Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both. World Allergy Organ. J. 2021: 14; 100501. IF: 5.52

o.410

Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both Read More »

Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria

172 Koti, I., Weller, K., Makris, M., Tiligada, E., Psaltopoulou, T., Papageorgiou, C., Baiardini, I., Panagiotakos, D., Braido, F., and Maurer, M.+: Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria. Dermatology 2013: 226; 371-379. IF: 1.68

Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria Read More »